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Abstract
Background: Anandamide is a lipid neurotransmitter which belongs to a class of molecules termed the endocannabinoids
involved in multiple physiological functions. Anandamide is readily taken up into cells, but there is considerable controversy
as to the nature of this transport process (passive diffusion through the lipid bilayer vs. involvement of putative proteic
transporters). This issue is of major importance since anandamide transport through the plasma membrane is crucial for its
biological activity and intracellular degradation. The aim of the present study was to evaluate the involvement of
cholesterol in membrane uptake and transport of anandamide.
Methodology/Principal Findings: Molecular modeling simulations suggested that anandamide can adopt a shape that is
remarkably complementary to cholesterol. Physicochemical studies showed that in the nanomolar concentration range,
anandamide strongly interacted with cholesterol monolayers at the air-water interface. The specificity of this interaction was
assessed by: i) the lack of activity of structurally related unsaturated fatty acids (oleic acid and arachidonic acid at 50 nM) on
cholesterol monolayers, and ii) the weak insertion of anandamide into phosphatidylcholine or sphingomyelin monolayers.
In agreement with these data, the presence of cholesterol in reconstituted planar lipid bilayers triggered the stable insertion
of anandamide detected as an increase in bilayer capacitance. Kinetics transport studies showed that pure
phosphatidylcholine bilayers were weakly permeable to anandamide. The incorporation of cholesterol in phosphatidyl-
choline bilayers dose-dependently stimulated the translocation of anandamide.
Conclusions/Significance: Our results demonstrate that cholesterol stimulates both the insertion of anandamide into
synthetic lipid monolayers and bilayers, and its transport across bilayer membranes. In this respect, we suggest that besides
putative anandamide protein-transporters, cholesterol could be an important component of the anandamide transport
machinery. Finally, this study provides a mechanistic explanation for the key regulatory activity played by membrane
cholesterol in the responsiveness of cells to anandamide.
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Introduction
Anandamide (arachidonoylethanolamide) is a lipid neurotrans-
mitter belonging to the family of endocannabinoids and involved
in the regulation of almost all the physiological functions studied
including the nervous, the cardiovascular, the respiratory, or the
reproductive systems [1]. The intracellular metabolism of
anandamide has been the subject of numerous studies. It is well
known that anandamide is produced from membrane phospha-
tidylethanolamine by a two-step reaction catalysed by membrane
N-acyl transferase and phospholipase D [2]. Then, intracellular
anandamide breakdown by a membrane fatty acid amide
hydrolase (FAAH) stops its biological activity [3]. Because of its
high lipophilicity together with its amphipathic nature ananda-
mide is generally considered to exert its biological effects in
membrane bilayers [4]. In this respect, two scenarios could be
proposed. First, anandamide could act directly in the physico-
chemical environment of the cell membrane which has produced it
(autocrine membrane-bound effect). However, anandamide can
also be released in the aqueous extracellular space, where,
probably transported by a protein carrier, it can reach and
stimulate neighbouring cells (paracrine effect). Anandamide
attachment to cannabinoid protein receptors, occurs through
binding sites deeply embedded in the lipid bilayer [4,5]. This
implies that anandamide has to gain entry into the membrane to
stimulate these receptors, which belong to the family of G protein-
coupled receptors with seven transmembrane domains.
Interestingly, molecular modeling studies have shown that
anandamide could generate either condensed hairpin or extended
rod-like structures [6]. This is consistent with a major conforma-
tional adjustment of anandamide structure during the reversible
transfer of the lipid neurotransmitter from a polar aqueous phase
to an apolar lipid phase. Recently, Tian et al. have carefully
studied the conformation, location, and dynamic properties of
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lamellar model membrane bilayer system [4]. They concluded that
the neurotransmitter can interact with phospholipids and then
laterally diffuse within the bilayer until reaching the transmem-
brane domains of cannabinoid receptors. However, several
important features of anandamide-lipid interactions remained to
be explored. In particular, the role of cholesterol in the interaction
of anandamide with biological membranes has not been
elucidated. Several aspects of anandamide function seem to
involve membrane cholesterol. Maccarone and co-workers showed
that cholesterol enrichment of glioma cell membranes significantly
increased the uptake of anandamide [7]. Reciprocally, depletion of
membrane cholesterol in hepatocytes membranes decreased their
responsiveness to anandamide [8]. Moreover, lipid rafts, which are
enriched in cholesterol, have been involved in the uptake and
recycling of anandamide [9]. Altogether, these data strongly
suggested that cholesterol could play a pivotal role in the
interaction of anandamide with biological membranes and thus
in its neurotransmitter activity. There are several ways by which
membrane cholesterol could affect anandamide functions. Re-
cently, Bari and co-workers reported that cholesterol modulates
the binding efficiency of the endocanninoid receptor CB1, and
that this effect is critical for anandamide-induced apoptosis [10].
However, in some cells, anandamide exhibited an apoptotic effect
which did not involve the cannabinoid receptors identified so far,
but were definitely cholesterol-dependent [8,11]. Whether these
latter effects are mediated by alternative protein receptors
functionally coupled to cholesterol, or by cholesterol itself through
a protein-independent mechanism, remains to be established.
Similarly, no consensus has been reached as to whether
anandamide transport through biological membranes requires a
protein transporter or not [12].
As stated above, anandamide is a lipid molecule which has to be
inserted in the plasma membrane to exert its neurotransmitter
activity. As a matter of fact, a simple way for cholesterol to control
anandamide functions would be to specifically bind to anandamide,
thereby controling its membrane insertion. In particular, a physical
interaction between cholesterol and anandamide would explain
why cholesterol appears so critical for many aspects of endocanna-
bonoid functions, including anandamide uptake and recycling [9],
CB1 activity [10], and receptor-independent apoptosis [8].
However, this possibility has not been experimentally tested. In
the present study, we have investigated the behaviour of
anandamide in various membrane environments with or without
cholesterol, using both monolayer and bilayer membrane models
systems. All the lipids used in these experiments were synthetic, so
that potential interference with undesirable membrane contami-
nantscould be totally ruledout. We show that anandamideinteracts
with cholesterol in both monolayer and bilayer systems. We also
show that cholesterol triggers the transmembrane transport of
anandamide. In complete agreement with these physicochemical
results, molecular modeling simulations suggested that cholesterol
has a remarkable fit for anandamide, explaining the striking
preference of anandamide for cholesterol among other major
membrane lipids such as phosphatidylcholine. Thus, whatever the
mechanisms by which anandamide triggers a biological effect,
cholesterol is able to regulate these effects because it binds to
anandamide in the membrane environment.
Results
Molecular modeling of anandamide bound to cholesterol
In membrane environments, anandamide adopts a typical
extended conformation, with its headgroup at the level of the polar
headgroup of phospholipids and its terminal methyl group near
the bilayer centre [4]. Molecular modeling simulations of
anandamide in vacuo led to a quite similar conformation of the
lipid (Figure 1A). When cholesterol was positioned in the vicinity
of anandamide, Monte Carlo simulations indicated that both lipids
progressively changed their conformation to find a remarkable
complementary fit. The resulting anandamide-cholesterol complex
Figure 1. Molecular modeling of anandamide-cholesterol
interactions. A- Spacefill model of a cholesterol-anandamide complex
in vacuo obtained with the Polak-Ribiere algorithm (for geometry
optimization) and then submitted to Monte Carlo simulations. The
extended conformation of anandamide in membrane environments is
consistent with the study of Tian et al. [4]. The methyl groups on the b
face of cholesterol fit particularly well with the cavities generated by the
double bonds of anandamide. The complex is stabilized by van der
Waals interactions and a hydrogen bond (yellow) between the OH
group of cholesterol (acceptor group) and the NH group of anandamide
(donor group). The total energy of the system is 48.12 kcal.mol
21
(22.81 kcal.mol
21 for anandamide bound to cholesterol). B- Compar-
ison of cholesterol-anandamide and cholesterol-sphingosine interac-
tions. The cholesterol-anandamide complex (left panel) is the same as in
(A), but shown in a tube representation. The cholesterol-sphingosine
complex [13] is shown in the left panel. Note that sphingosine has a
good geometric and chemical compatibility with the smooth a face of
cholesterol. Anandamide reacts similarly with cholesterol but with its
rough b face. The total energy of the system is 48.68 kcal.mol
21 for the
cholesterol-sphingosine complex (22.41 kcal.mol
21 for sphingosine
bound to cholesterol).
doi:10.1371/journal.pone.0004989.g001
Cholesterol and Anandamide
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parts and by a hydrogen bond between the OH group of
cholesterol and the NH group of anandamide. This molecular
complex respects the orientation of both lipids in biological
membranes. Although the extended conformation of anandamide
is consistent with an interaction with phospholipids [4], the perfect
fit between cholesterol and anandamide suggested a preferential
interaction of anandamide with cholesterol rather than with
phosphatidylcholine. Since we previously showed that cholesterol
also interacts with sphingosine [13], it was interesting to compare
the anandamide-cholesterol complex with the cholesterol-sphin-
gosine one. As shown in Figure 1B, anandamide interacts with
the b face of cholesterol which, according to the nomenclature
proposed by Rose and co-workers [14] is the ‘rough’ face with the
protruding methyl groups. In contrast, sphingosine binds to the
‘smooth’ a face of cholesterol. The respective energies calculated
for the cholesterol-anandamide and cholesterol-sphingosine com-
plexes are remarkably similar (see Figure 1 legend for details). As
biochemical studies have confirmed that sphingosine actually
interacts with cholesterol [13], these data suggest that the
interaction between anandamide and cholesterol is also very likely.
However, anandamide is a very flexible molecule whose
conformation might be strongly influenced by its environment
[4]. For these reasons, we studied the impact of vicinal membrane
lipids on the strength of the anandamide-cholesterol interaction.
Phosphatidylcholine, a representative lipid of the liquid disordered
(Ld) phase of the plasma membrane [15] was injected first in the
system. As shown in Figure 2, this lipid accommodated its
conformation to the shape of anandamide, and it had virtually no
impact on the anandamide-cholesterol complex. Then a sphingo-
momyelin molecule in tight interaction with cholesterol [15] was
introduced in the system as a representative component for the
liquid ordered (Lo) phase, which corresponds to lipid raft domains
[16]. Again, these lipids did not destabilize the anandamide-
cholesterol complex (Figure 2). Sphingomyelin readily bound to
the a face of cholesterol which is still fully accessible when the
sterol interacts with anandamide. Overall these data suggested that
a specific interaction between anandamide and cholesterol could
take place in both the Ld and the Lo phases of the plasma
membrane. Physicochemical experiments were then conducted to
assess whether anandamide could actually interact with cholesterol
in membrane environments.
Interaction of anandamide and structurally related
compounds with lipid monolayers
In a first series of experiments, we prepared various lipid
monolayers at the air-water interface and measured the interaction
of anandamide with these synthetic half-membranes using the
Langmuir film balance technology [13,17]. Anandamide (50 nM)
was injected in the aqueous subphase underneath the monolayer
and its interaction with the lipids was detected by a surface
pressure increase. This increase in the surface pressure is caused by
the insertion of anandamide molecules between the lipids of the
monolayer. It is a direct and quantitative measurement of the
interaction of a ligand (anandamide in this case) with a given lipid
[13]. Therefore, the higher the value of the surface pressure
increase induced by anandamide, the higher the affinity of
anandamide for a given lipid monolayer.
With this in mind, one can see in Figure 3 that anandamide
interacted more efficiently with cholesterol than with palmitoyl-
oleyl-phosphatidylcholine (POPC), a physiologically relevant
glycerophospholipid. Interestingly, the interaction with cholesterol
progressively increased over time until reaching a plateau value
(+7 mN.m
21) after 7 minutes. This value is remarkably close to
the one of +6 mN.m
21 obtained upon the addition of sphingosine
(50 nM) under a monolayer of cholesterol [13]. In contrast,
following a very rapid initial increase of surface pressure induced
by anandamide, the pressure of the POPC monolayer progres-
sively decreased to eventually return to the initial value. This
effect, which was reproducibly observed over six independent
experiments, suggests a decrease in the area of the monolayer,
which could be due to the extraction of either anandamide, or of
anandamide-POPC complexes, or of POPC alone. Moreover,
anandamide interacted with mixed cholesterol-POPC films, but
not with sphingomyelin (SM). Clearly, our data revealed a striking
selectivity of anandamide among major membrane lipid species
with a definitive preference for cholesterol.
An important issue was to assess whether similar results could be
obtained if structurally related lipids were assayed instead of
anandamide. Anandamide is metabolically derived from a
phospholipid precursor containing an unsaturated acyl chain
derived from arachidonic acid [2]. Thus we studied the interaction
of two unsaturated fatty acids, i.e. arachidonic acid and oleic acid,
with cholesterol monolayers. The molecular structures of these
compounds are shown in Figure 4. Both oleic and arachidonic
acids could fit with the apolar part of cholesterol and establisha H-
Figure 2. Molecular modeling of the anandamide-cholesterol
complex in the membrane environment. The anandamide (AEA)-
cholesterol complex was generated in vacuo, and subsequently merged
with a phosphatidylcholine molecule (PC). The flexible acyl chains of PC
could satisfactorily fit with AEA, allowing PC to interact with the AEA-
complex. A molecule of sphingomyelin (SM) interacting with cholesterol
was added to the system as a representative lipid raft component. The
SM-cholesterol complex could also fit with the AEA-cholesterol
complex. Namely, in the AEA-cholesterol complex, the a face of
cholesterol is fully accessible for the sphingosine chain of SM. This
molecular modeling study indicates that AEA can bind to cholesterol in
both the PC-rich fluid (Ld) phase and the SM-rich (Lo) phase of the
plasma membrane. In particular, the H-bond between cholesterol and
AEA is still present after introducing these membrane lipids in the
system. The total energy of the system is 180.68 kcal.mol
21 for the
cholesterol-sphingosine complex (214.43 kcal.mol
21 for AEA bound to
cholesterol). All models were obtained with the Polak-Ribiere algorithm
(for geometry optimization) and then submitted to Monte Carlo
simulations.
doi:10.1371/journal.pone.0004989.g002
Cholesterol and Anandamide
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induced only a very weak increase in the surface pressure
(+1 mN.m
21 after 500 seconds, compared with +7.5 mN.m
21
for anandamide) (Figure 5A). Oleic acid (50 nM) induced an
immediate decrease in the surface pressure (21 mN.m
21 after
5 seconds) followed by a very weak and progressive increase
(+0.5 mN.m
21 after 500 seconds). These data showed that in the
nanomolar concentration range, anandamide but neither oleic
acid nor arachidonic acid did interact with cholesterol monolayers.
To observe an interaction equivalent to the one induced by 50 nM
anandamide, the concentrations of arachidonic acid and oleic acid
had to be raised respectively to 500 nM and 750 nM. The
interaction of oleic acid (750 nM) with a cholesterol monolayer is
shown in Figure 5B. The surface pressure first increased
(+7 mN.m
21) shortly after the addition of oleic acid, after which
the surface pressure progressively decreased to reach a stable value
of 5 mN.m
21 after 400 seconds of incubation. At this time, we
injected an equivalent concentration of anandamide (750 nM) to
compare the effects of both lipids on the same cholesterol
monolayer. The surface pressure was dramatically increased upon
addition of this concentration of anandamide in the subphase until
reaching a stable plateau value (+23.5 mN.m
21) after 800 seconds.
Overall, these data showed that unsaturated fatty acids that are
structurally related to anandamide do not behave like anandamide
when probed on cholesterol monolayers. These results clearly
demonstrate that the interaction of anandamide with a pure
cholesterol monolayer is specific. Closely related amphipathic
molecules such as arachidonic acid and oleic acid can also interact
with cholesterol, but at significantly higher concentrations than
anandamide does (10 times and 15 times, respectively). In any
case, at all the concentrations tested in this study, the effects of
anandamide on cholesterol monolayers were always stronger than
those of fatty acids.
If one considers the molecular structure of anandamide and
arachidonic acid, this can be viewed as paradoxical. Indeed, the
polar part of arachidonic acid consists of a carboxylic group, which
displays an OH in place of the NH of anandamide. In the
anandamide-cholesterol complex shown in Figure 1, the
hydrogen atom of NH is involved in an H bond with the oxygen
atom of cholesterol. As shown in Figure 6B, a minimized
complex between the protonated form of arachidonic acid and
cholesterol can be obtained. This complex was then positioned in
front of a phosphatidylcholine molecule to mimic the membrane
environment. The short-term evolution of this cholesterol-
arachidonic acid complex, constrained by phosphatidylcholine,
was studied in silico by molecular dynamics simulations. After
3 ps, arachidonic acid had detached from cholesterol to adopt a
conformation more fitted to the apolar flexible chains of
phosphatodylcholine (Figures 6C). At this time, the hydrogen
bond and several van der Waals interactions that were initially
involved in the cholesterol-arachidonic acid complex had been
broken. For comparison, we studied the evolution of a cholesterol-
anandamide complex under similar conditions. In marked contrast
with the data obtained with arachidonic acid, the anandamide-
cholesterol complex had remained remarkably stable after 3 ps of
simulation, with its stabilizing hydrogen bond still operative
(Figure 6A). These modeling studies, which are in line with the
physicochemical data, suggest that cholesterol has a higher affinity
for anandamide than for arachidonic acid. This specific issue will
be further discussed below.
Figure 3. Interaction of anandamide with various lipid
monolayers. The indicated lipid was spread at the air-water interface
to form a compressible monolayer at an initial pressure comprised 20–
25 mN.m
21. After stabilization of the monolayer, anandamide was
added in the aqueous subphase (final concentration 50 nM). Under
these specific conditions, anandamide does not modify the surface
tension of water (not shown), so that it will have no effect on the
surface pressure by itself. Thus, any change in the surface pressure
indicates an interaction of anandamide with the lipid monolayer. The
data are expressed as the variation of the surface pressure as a function
of time following the addition of anandamide. The following lipids were
spread at the air-water interface: pure POPC (full squares), pure
cholesterol (open squares), mixed POPC-cholesterol film (1:2, mol:mol,
open triangles), pure SM (full triangles).
doi:10.1371/journal.pone.0004989.g003
Figure 4. Chemical structures of cholesterol, anandamide and
unsaturated fatty acids. Unsatutared fatty acids (arachidonic acid
and oleic acid) are structurally related to anandamide. The interaction of
cholesterol with these fatty acids, in comparison with anandamide, is
shown in Figure 5.
doi:10.1371/journal.pone.0004989.g004
Cholesterol and Anandamide
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To characterise the biophysical mechanisms responsible for
cholesterol-dependent anandamide interactions, we prepared
planar lipid bilayer membranes [18] of controled biochemical
compositions. In this model, a bilayer is formed by injecting with a
Hamilton syringe, 1–2 ml of a concentrated lipid solution (POPC
or POPC-Cholesterol, 50 mg/ml) in a hole drilled in the wall of a
Delrin chamber (200 mm diameter) thus separating two compart-
ments. The formation of a gigaohm-seal characteristic of an
operating membrane has been systematically monitored electro
physiologically. Ag/AgCl electrodes are used to record the
electrical variations induced by the ionic fluxes crossing through
the membrane. One electrode is connected to the amplifier and
dipped into the Delrin chamber thus defining the cis compart-
ment. The other is connected to the ground and defined the trans
compartment. Thus, this experimental setup is adequate to
evaluate the insertion of organic compounds within the lipid
bilayer.
Figure 5. Interaction of arachidonic acid, oleic acid and
anandamide with cholesterol monolayers. A. Monolayers of pure
cholesterol were prepared at the air-water interface at an initial
pressure of 25 mN.m
21. After stabilization of the monolayer, arachi-
donic acid (open squares), oleic acid (full triangles) or anandamide (full
squares) were injected in the aqueous subphase at a final concentration
of 50 nM. The data are expressed as the variation of the surface
pressure as a function of time following the addition of the indicated
lipid in the subphase. B. A monolayer of cholesterol (initial pressure of
25 mN.m
21) was incubated with 750 nM of oleic acid added in the
subphase. Under these conditions, the surface pressure of the
monolayer rapidly increased and reached a stable value of
5m Nm
21. After 400 seconds, 750 nM of anandamide (AEA, arrow)
was injected in the aqueous subphase, which induced a dramatic
surface pressure increase.
doi:10.1371/journal.pone.0004989.g005
Figure 6. Molecular dynamics simulations of cholesterol-
anandamide and cholesterol-arachidonic acid minimized com-
plexes in a membrane lipid environment. A- Geometry optimiza-
tion of anandamide (AEA) interacting with both cholesterol (chol) and
phosphatidylcholine (PC). The molecules with the carbon atoms in blue
correspond to the initial conditions (energy minimum complex
simulated in vacuo with the Polak-Ribiere algorithm). Molecular
dynamics simulations of the AEA-cholesterol complex were then
conducted in vacuo with the MM+ force field. The respective positions
of AEA and cholesterol after 3 ps of simulation are indicated in green.
One can see that AEA is still tightly bound to cholesterol, indicating that
PC had little influence on the geometry of the AEA-cholesterol complex.
B- Tube representation of a minimized complex between arachidonic
acid (a.a) and cholesterol. The model was obtained with the Polak-
Ribiere algorithm using the anandamide-cholesterol complex of
Figure 1 as template. The H bond between the –COOH group of
arachidonic acid and the OH group of cholesterol is indicated as a dot
line. C- Spacefill models showing the evolution of the cholesterol-
arachidonic acid complex (in presence of a PC molecule shown in a
tube representation) after 3 ps of molecular dynamics simulations. The
initial conditions are shown in the left panel, and the geometry
obtained after 3 ps of simulation in the right panel. The system has
spontaneously evolved toward the dissociation of arachidonic acid from
cholesterol (arrow). The conformation of arachidonic acid after 3 ps is
more fitted to the geometry of the vicinal PC molecule than to the
sterol. This suggests that in the membrane environment, the affinity of
cholesterol for arachidonic acid is weaker than for anandamide.
Consequently, the complex between cholesterol and arachidonic acid
is predicted to be less stable than the complex between cholesterol and
anandamide.
doi:10.1371/journal.pone.0004989.g006
Cholesterol and Anandamide
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solution to aqueous buffers is debated among investigators. As a
matter of fact, anandamide transport studies, which require higher
anandamide concentrations than those we used in the monolayer
assay, are generally conducted in presence of bovine serum
albumin [19], which improves anandamide solution stability and
minimizes its binding to plastic surfaces [12]. However, it has also
been reported that serum albumin could generate some artifacts in
transport studies [20]. Furthermore, in our hands, bovine serum
albumin appeared to be deleterious for planar bilayer membranes
(not shown). Finally, the spectroscopic method used for ananda-
mide detection does not allow the use of a protein carrier such as
serum albumin. Thus we decided to use methyl-beta-cyclodextrin
(MbCD) to prepare aqueous anandamide solutions useable for
planar bilayer studies. Indeed, cyclodextrins are well known for
their ability to increase substantially the aqueous solubility,
stability and bioavailability of lipophilic drugs, so that they are
suitable carriers for anandamide [21]. In this respect, it should be
noted that only the free drug, and not the cyclodextrin-drug
complex can penetrate across the biological membranes [22]. In
any case, we carefully controled that under our experimental
conditions, 4.2 mM of MbCD alone has no effect on the
capacitance and resistance of lipid bilayers (not shown). Then
we added anandamide in presence of MbCD in the cis
compartment in which a functional membrane of pure POPC
had been formed by the injection method [18]. Figures 7A and
7B show the resulting currents after a 180 mV voltage pulse. In
response to anandamide, there was a transient increase in the
bilayer capacitance during the first minute (not shown), followed
after 5 minutes by a stable capacitance decrease of 1568%
(p,0.05; range: 14–2 mF/cm
2,n=7 ,Figure 8A). Therefore, the
evolution of this electrical parameter in response to anandamide is
fully consistent with the interaction of anandamide with a POPC
monolayer (initial increase of the surface pressure followed by
progressive decrease as shown in Figure 3). Changes in
capacitance are due to the variations of the actual membrane
surface [18]. The time-course of the electrical resistance of the
membrane bilayer evolved similarly, with a decrease of 26612%
(p,0.05, range: 4.2610
4–0.2610
4 ohm-cm
2,n = 7 ,Figure 8B).
From these studies conducted with two distinct model membranes
it can be concluded that: i) anandamide interacts with POPC, ii)
this interaction is rapidly reversible, and iii) the presence of
anandamide in pure POPC phases could modify the phospholipid
organisation.
Figure 7. Action of anandamide (AEA, 400 mM) on planar lipid bilayers: effect of cholesterol. A–B. superimposed currents across a bilayer
constituted of POPC alone (A), held at 0 mV, in response to a rectangular pulse (+180 mV, 200 ms), before (control, light grey bilayer alone), and after
addition of anandamide (heavy grey, +5, +25 min after AEA injection). B. Expanded view of tail currents (I tail) showing their decrease over time. C–D.
POPC-cholesterol (2:1, mol:mol). AEA injection (C) stably increased both resistance and capacitance. Maximum effect was obtained for all POPC-
cholesterol bilayers within 3–5 min. Each current trace represents the average of 6 records.
doi:10.1371/journal.pone.0004989.g007
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and 7D) highly stimulated anandamide insertion. Namely, when
added on a bilayer with a molar POPC-cholesterol ratio of 2:1
(mol:mol), anandamide induced an immediate and permanent
increase in capacitance, 1969% (p,0.01, range: 100–8 mF/cm
2,
n=7,Figure 8C), indicating a stable insertion process. This is in
line with the results obtained with cholesterol monolayers
(Figure 3). Interestingly, anandamide also increased the resistance
of the membrane by 1665% (p,0.01, range: 3.8610
4–
4.1610
4 ohm-cm
2,n = 7 ,Figure 8D), which indicated that the
integrity of bilayers was not compromised by anandamide.
Translocation of anandamide through lipid bilayers
The next issue addressed herein was to determine whether
cholesterol has any impact on the membrane translocation of
anandamide. Using the same bilayer design, we studied the
kinetics of anandamide transport through POPC bilayers prepared
with various cholesterol amounts. Anandamide (1 mM) was added
Figure 8. Modification of bilayers electrical properties. A–D. dotted line, control; solid line, after AEA injection. Intensity-Voltage curves were
obtained from the relaxation tail currents plotted against voltage, and current reading at 225 ms and 425 ms (POPC and POPC-cholesterol
respectively). Capacitance-Voltage curves, I0 reading was also at 225 and 425 ms, and It 100 ms later. Error bars were calculated after current
acquisitions from six repeated protocols, from the same membrane, and then fed to the analysis programme.
doi:10.1371/journal.pone.0004989.g008
Cholesterol and Anandamide
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4.2 mM MbCD. The concentration of anandamide in each
compartment at various times was determined by an enzymatic
assay based on the 5-lipoxygenase catalysed reaction on cis-cis 1–4
pentadiene structure systems [23] (threshold detection level
2.5 nmol of anandamide). The data in Figure 9A clearly shows
that pure POPC membranes have a very weak permeability to
anandamide. Above a critical threshold level, the presence of
cholesterol in the POPC matrix strongly stimulated the translo-
cation of anandamide. For instance, after one hour, cholesterol
increased by twelve times the amount of AEA transfer
(Figure 9B). The electrical parameters of bilayers were assessed
by electrophysiological monitoring, so that we can be certain that -
under our experimental conditions – the presence of MbCD did
not affect the integrity of the bilayers, whatever their cholesterol
content (in the range of 8:1 to 2:1 POPC:cholesterol molar ratio).
In particular, the increase in membrane capacitance measured
upon incubation of MbCD-anandamide complexes with choles-
terol containing lipid bilayers demonstrates that, under these
conditions, MbCD does not extract cholesterol. This is fully
consistent with the data independently obtained by Ohvo and
Slotte [24] who showed that cyclodextrin-dependent cholesterol
extrusion from model membranes requires a high excess of
cholesterol vs. phospholipids, which is not the ratio we used in our
experiments. Finally, POPC-cholesterol bilayers incubated only
with 4.2 mM of MbCD, were totally impermeable to glucose (data
not shown), which demonstrated that these membranes were not
leaky to small polar molecules.
Discussion
The main outcomes of the present study can be summarized as
follows: i) anandamide can adopt a specific conformation
compatible with a high affinity interaction with cholesterol; ii)
although anandamide can interact with phosphatidylcholine [25],
cholesterol greatly facilitates its insertion into reconstituted model
membranes; and iii) the presence of a threshold level of cholesterol
is sufficient to induce the translocation of anandamide through a
protein-free membrane. Such threshold levels could correspond to
local enrichments of the plasma membrane in pure cholesterol
which could exist for instance at the boundaries of lipid raft
domains [16,26].
That anandamide could interact with cholesterol has been
previously suggested by Biswas et al. on the basis of the binding of
cholesterol to anandamide-coated polymixin beads [8]. However,
this experimental system does not adequately reflect the
orientation and organization of cholesterol in a biological
membrane. In addition, the lipid specificity of the interaction
has not been investigated by these authors, so that we cannot
conclude from their study whether anandamide has a general
affinity for lipid molecules or a specific fit for cholesterol. In our
study, we show that one peculiar anandamide conformation
displays a remarkable complementary fit for cholesterol (Figure 1).
Molecular modeling approaches indicated that anandamide
interacts with the b face of cholesterol. Interestingly, previous
studies suggested that sphingosine, which also binds to cholesterol,
recognizes its a face [13]. These geometric features allow
cholesterol to interact simultaneously with anandamide and with
sphingolipids. Moreover, the energy calculations of cholesterol-
anandamide and cholesterol-sphingosine interactions appeared to
be remarkably similar, suggesting highly specific interactions in
both cases. The surface pressure values measured during the
interaction of cholesterol monolayers with anandamide and with
sphingosine were also fully consistent (ca. +6–7 mN.m
21 for the
concentration of 50 nM for both sphingosine and anandamide).
These data, obtained with lipid monolayers, were fully
confirmed by the physicochemical studies of bilayer model
membranes, which demonstrated that the presence of cholesterol
dramatically increased the insertion of anandamide into the lipid
phase. It should be noted that the capacitance values obtained
with this system were significantly higher than those obtained in
comparable studies of synthetic phospholipid bilayers probed with
penetrating compounds [27]. This indicates that the cholesterol
Figure 9. Kinetics of anandamide transport through planar
lipid bilayers: effect of cholesterol. Planar lipid bilayers consisting
of pure POPC (full triangles), or various mixtures of POPC and
cholesterol [molar: molar 2:1 (full squares), 4:1 (open squares), 5:1 (full
circles), 8:1 (open circles)] were obtained as described for electrical
measurements. A. Anandamide (1 mM) was added to the cis
compartment in presence of 4.2 mM MbCD. The amount of ananda-
mide recovered in the trans compartment was enzymatically measured
using an anandamide assay with 5-lipoxygenase. B. Anandamide
transport as a function of cholesterol percentage in the POPC bilayer.
The experimental points correspond to the amount of AEA in the trans
compartment 1 hour after its addition in the cis compartment. The
sigmoidal shape of the cholesterol effect suggests that a threshold level
of cholesterol is required to trigger the translocation of AEA. This is
consistent with the recruitment of cholesterol molecules into tail-to-tail
dimers as the ordered supramolecular cholesterol structure used by
AEA to cross the membrane. On the opposite, a further excess of
cholesterol (full squares, panel A) would condense into non functional
nanodomains unable to further increase the kinetics of AEA transport.
doi:10.1371/journal.pone.0004989.g009
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not a borderline phenomenon but a quantitatively significant
process.
As the bilayer system is particularly well suited for transport
studies, we could also analyze the effect of cholesterol on the
translocation of anandamide. Our data clearly showed that
bilayers consisting of POPC alone were only weakly permeable
to anandamide. This agreed with the low affinity of anandamide
for POPC measured in both monolayer and bilayer systems.
However, in presence of a threshold level of cholesterol, the
transport of anandamide through the synthetic membrane was
greatly enhanced. On this basis, one could hypothesize that
anandamide could interact chiefly with cholesterol enriched
domains such as lipid rafts [9], and especially the boundaries of
these domains where local cholesterol clusters could modulate the
interaction of these domains with the bulk membrane [16,26].
Until now, the mechanism of anandamide transport through a
biological membrane is matter of debate [12,28]. According to
some authors, anandamide passively diffuses through the
membrane, its transmembrane gradient being maintained by
the intracellular action of FAAH which hydrolyses anandamide
into arachidonic acid and ethanolamine [29]. Because the
transport of anandamide is saturable and specifically inhibited
by anandamide analogues that are not broken by FAAH, other
authors argue for the existence of a proteic transporter for
anandamide [30]. An important specificity of the present study is
that the different model membranes used (monolayers and
bilayers) were built with synthetic lipids. Accordingly, we could
totally rule out the possibility that some of the observed effects
could be due to protein contaminants. Indeed, our data clearly
indicate that cholesterol has the intrinsic property to stimulate
both the insertion and transmembrane transport of anandamide.
Thus, even though a putative protein anandamide transporter
can exist, clearly this latter is not compulsory. Further studies will
help to clarify the role of membrane cholesterol in anandamide
transport, especially its saturability and sensitivity to anandamide
analogues.
Our data are also consistent with the observation that the
uptake of anandamide is inhibited by cholesterol depleting agents,
and stimulated by membrane cholesterol enrichment [7]. The
ability of anandamide to recognize and bind to membrane
cholesterol could also explain why anandamide uptake and/or
biological effects are modulated by pharmacological agents that
affect the homeostasis of lipid rafts (cholesterol-enriched micro-
domains) [9,10]. As for the effects of anandamide that are
mediated by its well-characterized protein receptors such as CB1
[8], cholesterol could exert two distinct (yet not mutually exclusive)
functions: i) modulation of receptor conformation with an impact
on ligand binding efficiency, and ii) facilitation of the transfer of
anandamide to the protein receptor following its insertion into the
membrane. Finally, the cholesterol-anandamide interaction could
also be responsible for the effects of anandamide that do not
appear to involve its classical transmembrane protein receptors
[8,11,31].
An intriguing and perhaps unexpected aspect of the
interaction of anandamide with cholesterol is its relative
specificity. We have shown that unsaturated fatty acids
structurally related to anandamide do not interact with
cholesterol monolayers unless their concentration is raised to
500 nM for arachidonic acid (10 times higher than anandamide)
and 750 nM for oleic acid (15 times higher than anandamide).
This can be interpreted as a better affinity of cholesterol for
anandamide than for unsaturated fatty acids such as the
arachidonic acid. The apolar parts of arachidonic acid and
anandamide are identical. The difference lies in the polar part,
which is a carboxylic group for the fatty acid and ethanolamide
for anandamide. As a matter of fact, the ethanolamide group has
a marked impact on the stability of the anandamide-cholesterol
complex, as suggested by molecular dynamics simulations. Yet
the low activity of arachidonic acid on cholesterol monolayers
could also be due to the dissociation equilibrium of the
carboxylic group. The pKa of this group for polyunsaturated
fatty acids is close to pH 8, but is known to fall towards pH 7
for diluted solutions [32]. Thus, under the experimental
conditions of the monolayer experiments, arachidonic acid
might indeed be a balanced mixture of negatively charged and
neutral protonated molecules. Since only the protonated form of
the acid could establish an H bond with the oxygen atom of
cholesterol, this feature could also explain the instability of
arachidonic acid-cholesterol complexes (this effect was not
studied in our molecular dynamics simulation). In contrast,
anandamide is a neutral molecule and the hydrogen atom of its
NH group is not labile. This makes the H bond between
anandamide and cholesterol particularly stable.
Overall, our physicochemical data indicated that i) anandamide
preferentially interacts with cholesterol in monolayer and bilayer
systems (compared with other membrane lipids such as POPC or
sphingomyelin), and ii) this effect is specific for anandamide as
assessed by the study of structurally related compounds (arachi-
donic acid and oleic acid).
Conclusion
Our demonstration of a specific interaction between ananda-
mide and cholesterol has important consequences for the
neurobiology of anandamide. The efficient transfer of anandamide
from the aqueous phase (i.e. bound to a carrier protein) to the
plasma membrane is associated with a reduction of dimensionality
from a three-dimensional space to a two-dimensional surface
diffusion [33]. Consequently, the concentration of anandamide in
the membrane could be of several levels of magnitude higher than
in the intercellular space. Since cholesterol is present in both
leaflets of the plasma membrane [34], it could trigger the
bidirectional translocation of anandamide (according to the
concentration gradient of the neurotransmitter). Indeed, ananda-
mide could be transferred from one membrane leaflet to the other
by cholesterol dimers adopting a tail-to-tail configuration [34].
This transmembrane transport is still consistent with a passive
diffusion mechanism, but involving a cholesterol concentration
threshold as illustrated in Figure 9. Finally, whether anandamide
bound to cholesterol could be laterally transported in the plane of
the membrane and delivered to its transmembrane receptors CB1
and CB2 warrants further investigation.
Materials and Methods
Materials
Synthetic lipids of the higher purity available were purchased
from Sigma. Pure water was from BIORAD. All other reagents
were from Sigma.
Molecular modeling
Geometry optimization of each cholesterol-lipid complex was
first achieved with the Polak-Ribiere algorithm. Monte Carlo
(Figures 1, 2) and molecular dynamics simulations with the
MM+ force field (Figure 6) were then performed in vacuo with
the Hyperchem 7.5 program (ChemCAD, Obernay, France) as
described previously [13,17].
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The surface tension was measured with a fully automated
microtensiometer (mTROUGH SX, Kibron Inc. Helsinki, Fin-
land). All experiments were carried out in a controled atmosphere
at 20uC61uC. Anandamide (stock solution prepared in hexane:-
chloroform:ethanol; 11:5:4; vol:vol:vol and saturated under a
nitrogen flux) was injected in the pure aqueous subphase (volume
of 800 ml) with a 10 ml Hamilton syringe, and the variations of the
surface pressure were continuously recorded until reaching
equilibrium. The data were analyzed with the Filmware 2.5
program (Kibron Inc. Helsinki, Finland) as described previously
[13,17]. The accuracy of the system under our experimental
conditions was 60.25 mN.m21 for surface tension. To compare
the effects of anandamide, arachidonic acid and oleic acid, 1006
solutions of these lipids were prepared in 100 mM NaCl and
injected in the aqueous subphase.
Reconstituted planar lipid bilayers
Planar lipid bilayers were formed over a 200 mm diameter
circular hole, in a vertical wall of a Delrin chamber (Warner
instruments), by the injection method [18]. The membrane
forming solution consisted of palmitoyl-oleoyl-phosphatidylcholine
(POPC) or POPC/cholesterol (2:1; 4:1; 8:1, mol/mol; synthetic
lipids purchased from Sigm). The bilayers were obtained by
injecting 1 ml of lipids (50 mg/ml in: hexane/chloroform/ethanol,
11/5/4, v/v/v) with a Hamilton syringe. The aperture was not
pre-treated before the injection of lipids.
Electrical recordings
All experiments were performed in 0.1 M KCl, 0.001 M 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (pH 7.2;
Sigma; H2O from Biorad). Each compartment contained 1.4 ml of
this solution. An Ag/AgCl electrode connected to a patch-clamp
amplifier (Axopatch 200B, Digidata 1200, Axon Instruments) via a
probe was immersed (using a glass micropipette, 1–2 GV) in the
cis compartment, the trans compartment was connected to the
ground. The formation of bilayers was electrically monitored by
measuring online the membrane apparent resistance (25 mV/
0.5 s). After lipid injection, a gigaohm (GV) seal was obtained
within seconds. Membranes were maintained at zero mV in
voltage clamp mode and typically stabilized at 280 pA in these
ionic conditions. Capacity increased with time until a steady-state
value some 2–10 min later and considered as membrane
stabilization. This was controled by the total reduction of the leak
current after a 100 mV- 1 s pulse, probably reflecting the solvent
elimination. Electrical apparent resistance ranged 10–40 GV for
POPC and POPC-cholesterol bilayers. The breakdown potential
was estimated around 220–250 mV using rectangular voltage
steps. Since fluctuations of currents were typically observed for
steps by 200 mV (assessed over a hundred bilayers), the maximum
voltage step was set at 180 mV. Experiments were performed at
room temperature. One mmole of AEA from an ethanolic stock
solution (10 mM) was dried in saturated nitrogen atmosphere then
resuspended in 50 ml of methyl-beta-cyclo-dextrin (MbCD)
solution (87 mM) and injected in the cis compartment. The same
volume of MbCD 87 mM was injected in the trans compartment.
Only one injection of AEA was performed per bilayer. Different
POPC/cholesterol ratios were tested in the present work (from
16:1 to 2:1) and only the 2:1, corresponding to the most efficient
ratio for transport of AEA through bilayers, is described and
illustrated in Figure 5. There was no capacitance modification for
16:1 and 8:1 ratios. The 4:1 ratio gave only one minor capacitance
variation over ten bilayers. Thus, no graded response was
observed from 16:1 to 2:1 POPC/cholesterol ratios, suggesting a
threshold effect of cholesterol concentration.
Data analysis. Off-line analysis was carried out using the
subroutine Clampfit of the Pclamp6 software to export data.
Membrane resistance and capacitance were calculated using a
home-made (with Matlab) computer analysis programme (see
below). Electrical resistance was obtained by impressing a family of
voltage step across the membrane (30 mV/2 s) and calculated
according to the ohm’s law RM=(E M/Ei2EM)*Ri where Ri is the
series resistance (stated at 1 MV, which is the resistance of a glass
pipette), Ei is the calibrated input voltage, and EM is the voltage
across the bilayer. Current/voltage (I/V) curves were generated
from the BLM current responses, as a function of applied voltage.
The experimental transmembrane resistance RM (in ohms) was
converted to the normalized transmembrane resistance Rm (in
ohm-cm
2) by calculating the product of RM times the membrane
area (A). Since A is usually expressed in cm
2, the equation
becomes Rm=R M*A.
Rm varied linearly in the 30–60 mV voltage range, in both types
of bilayers. From 60 to 180 mV, POPC I/V curves remained
linear after a change in slope, whereas POPC-cholesterol bilayers
exhibited a slight rectification, and a change in slope. The steady-
state current for a 180 mV pulse taken as reference, was obtained
around 200 ms and 400 ms for POPC and POPC-cholesterol
bilayers respectively.
To discard the difficulty of tau (time constant) evaluation online,
the planar lipid bilayer capacitance was calculated from the
modified equation: Cm=t/Rpln(I0/It) [18] where t=time in
seconds, I0 is the steady state current at t=0, It is the current at
time t, and Rp is the leakage resistance given by Rp=R mRi/Rm+Ri
for potentials from 30–60 mV. Rp was included in the Cm
equation and extrapolated for the complete potential range (30–
180 mV). Cm decreased with increased potentials for all bilayers
in a bell-shape behavior.
Analysis programme. The resistance is calculated according
to Ohm’s law
U~R   I ð1Þ
i.e.
R~U=I ð2Þ
Which is normalized to the membrane area
Rm~RM   Am ð3Þ
To calculate the membrane capacitance (see below) the term Rp
(leakage resistance) was obtained from:
Rp~
RmRs
RmzRs
ð4Þ
where Rm comes from equation (3) and Rs is the series resistance
given by the resistance of the glass micropipette (1 MV)
Statistical data and consequences on mean and standard
error for lipid bilayer capacitance
Current traces averaging and standard error. Average
traces are calculated for six different files obtained for a same
voltage step. To each point is associated the mean and standard
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x~
1
n
X n
i~1
xi
And standard error from:
S~
1
n
X n
i~1
xi{x ðÞ
2
 ! 1
2
Stat reminder
Two data series a and b with a mean of
a,b
And standard error
Sa,Sb
1. Mean and standard error of a sum
Then the data series y=a+b has a mean of
y~azb
And standard error
Sy~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
S2
azS2
b
q
2. Mean and standard error of a product and a quotient
The data series y=a * b ou y=a/b has a mean of
y~a   b
Or
y~
a
b
And standard error of
Sy~y  
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Sa
a
   2
z
Sb
b
   2
s
3. Logarithm
y~log10 a ðÞhas a mean of y~log10 a ðÞand standard error
Sy~0:434  
Sa
a
Mean and standard error for lipid bilayer capacitance
Cm~
t
Rp   log
I0
It
   ð5Þ
Modified from Ti Tien [18]
Given am a,sa ðÞ , bm b,sb ðÞ , cm c,sc ðÞ , dm d,sd ðÞ
Then it comes: y~
a
b:log
c
d
  
Which has a standard error of:
Sy~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
5:31:log2 mc
md
  
log2 10 ðÞ :
m2
d
s2
d
z
m2
c
s2
c
 ! z
m2
b
s2
b
z
m2
a
s2
a
v u u u u u u u u t
mb:log
mc
md
  
Calculated with maxima-5.5 (created by W. Schelter;http://
ww3.ac-poitiers.fr/math/prof/logic/gos6/)
And a mean of : my~
ma
mb:log
mc
md
  
Formulas were checked using Matlab and test vectors of known
mean and standard errors.
Transport of anandamide through a reconstituted planar lipid
bilayer
Kinetics of 1 mmole anandamide transport across planar lipid
bilayers of controled lipid composition were carried out at 20uC
using planar lipid bilayer chambers from Warner Instrument as
described above. The anandamide transport is measured with an
anandamide assay at various times using 5-lipoxygenase from
soybean. An excess of 5-lipoxygenase (50.000 units, type I-B
Sigma) catalyses at 20uC in 1.1 ml of 0.1 M carbonate/
bicarbonate buffer, 2% Tween 20, (Sigma), pH 9, the complete
hydroperoxydation of lipids containing cis-cis pentadiene structure
as linoleic acid, arachidonic acid or anandamide [23]. The
reaction is followed by measuring the increase in absorbance at
234 nm against lipoxygenase solution in 2% Tween 20. One
enzymatic unit causes an increase in absorbance at 234 nm of
0.001 per minute at 20uC at pH 9 when linoleic acid is used as
substrate. The soybean 5-lipoxygenase uses anandamide as
substrate with approximately 15% of the activity indicated using
linoleic acid. The amount of anandamide accumulated in the trans
compartment was estimated considering that one absorbance unit
at 234 nm is equivalent to the oxidation 0.12 micromole of
anandamide, on the basis of a calibration curve.
Experimental data were analysed with the Origin programme,
version 3.5 (Microcal software). The Boltzman (x,A1,A2,x0,dx)
function producing a sigmoidal curve was used according to the
equation:
(A1–A2)/[1+exp((x2x0)/dx)]+A2 with parameters of x0 (center,
i.e., x at y50), dx (width), A1 (Y initial), and A2 (Y final).
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